Shots:

• Bain Capital and Cinven to acquire Lonza’s specialty ingredients business and operations for an enterprise value of $4.7B. The transaction is expected to close in H2’21
• The divestiture will allow Lonza to refocus its business as a pure-play partner to the healthcare industry
• Lonza’s specialty ingredients business provides microbial control solutions for Professional Hygiene and Personal Care products and offers the custom development and manufacturing of specialty chemicals and composites to support the electronics- aerospace- food and agrochemical industries

 ­ Ref: Lonza | Image: 24 News Update Blog